CLASS III ONGOING Device recall · Reported 15 Jan 2025 · FDA Enforcement Report

The FastPack IP Sex Hormone Binding Globulin Immunoassay recalled

Qualigen is recalling The FastPack IP Sex Hormone Binding Globulin Immunoassay, Part #25000081, is for the, distributed in 15 states. The recall was initiated on 3 Dec 2024 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesUDI-DI: 20816467020345, Lot numbers: 2408018-1 Exp: 2025-09-05; 2409015-1, Exp: 2025-06-27; and 2409015-2, Exp: 2025-06-26.
Quantity recalled426

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0805-2025
FDA event ID
95807
Recalling firm
Qualigen, Carlsbad, CA
Classification
Class III
Status
Ongoing
Recall initiated
3 Dec 2024
FDA classified
3 Jan 2025
Reported
15 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

3 Dec 2024Recall initiated by company
3 Jan 2025Classified by FDA+31 days
15 Jan 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Three lots of the FastPacks kitted into the FastPack SHBG Complete Kits were labeled with the incorrect expiration date. The following is a listing of affected lots: Lot Number: 2408018-1, 2409015-1, and 2409015-2. The likelihood of patient harm is expected to be low as routine Quality Control should detect kits that are impacted by signal deterioration due to age.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

The FastPack IP Sex Hormone Binding Globulin Immunoassay, Part #25000081, is for the quantitative measurement of SHBG in human serum and plasma. For in vitro diagnostic Use and contains 30 FastPacks.

Where it was distributed

Distribution was made to AR, CA, CO, FL, IL, IN, MA, MO, NC, NY, OH, OK, TN, TX, and VA. There was no military/government/foreign distribution.

ArkansasCaliforniaColoradoFloridaIllinoisIndianaMassachusettsMissouriNorth CarolinaNew YorkOhioOklahomaTennesseeTexasVirginia

Questions about this recall

Why was it recalled?

Three lots of the FastPacks kitted into the FastPack SHBG Complete Kits were labeled with the incorrect expiration date. The following is a listing of affected lots: Lot Number: 2408018-1, 2409015-1, and 2409015-2. The likelihood of patient harm is expected to be low as routine Quality Control should detect kits that are impacted by signal deterioration due to age.

Which lots are affected?

UDI-DI: 20816467020345, Lot numbers: 2408018-1 Exp: 2025-09-05; 2409015-1, Exp: 2025-06-27; and 2409015-2, Exp: 2025-06-26.

Where was it sold?

Distribution was made to AR, CA, CO, FL, IL, IN, MA, MO, NC, NY, OH, OK, TN, TX, and VA. There was no military/government/foreign distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Qualigen

All 8

Other Test Kits & Diagnostics recalls

All 2,663